FAFP, May 12 / PRNewswire-FirstCall-Asianet /-- according to the latest paper in the journal Communication Biology, Nature, a study from the University of Pompeii Fabra in Spain identified Schlafen 12 (SLFN 12) as a new HIV limiting factor. SLFN 12 blocks the production of viral proteins and helps infected cells escape anti-HIV treatment and immune response. These findings pave the way for improving treatment strategies for HIV infection.